Summary of Preoperative HbA1c Guidance from Adjacent Surgical and Medical Specialties
| Society/Guideline | Specialty | HbA1c Threshold | Key Recommendation |
|---|---|---|---|
| ADA Standards of Care 2024–2025 | Endocrinology Surgery | < 8.0% | Target < 8% before elective procedures; individualize based on hypoglycemia risk |
| CPOC Elective Surgery Guideline 2023 (UK) | Perioperative Medicine | < 8.5% (69 mmol/mol) | Recommend referral to diabetes specialist team if HbA1c ≥ 8.5% (69 mmol/mol); timing of elective surgery adjusted accordingly to permit preoperative optimization |
| ESC Non-Cardiac Surgery Guidelines 2022 | Cardiovascular Surgery | Screen; optimize preoperatively | Class 1 (Level B): HbA1c test recommended for all patients with diabetes or disturbed glucose metabolism before NCS; elective surgery postponed if HbA1c ≥ 69 mmol/mol (8.5%), if safe and practical |
| SAMBA Consensus Statement 2024 (Rajan et al., Anesth Analg.) | Anesthesiology | No HbA1c-based deferral threshold; day-of-surgery glucose is the operative metric | No postponement based on HbA1c alone; day-of-surgery point-of-care glucose measurement required; proceed if DKA/HHNS absent; intraoperative glucose target 180–250 mg/dL |
| ASPS Member Practice Guidelines | Plastic/Cosmetic Surgery | ≤ 7.0–7.5% preferred | Many ASPS members prefer HbA1c ≤ 7.0%–7.5% for elective cosmetic procedures; multidisciplinary coordination required |
| Mohs/Dermatologic Surgery literature | Dermatologic Surgery | < 7.5–8.0% for elective procedures | Preoperative HbA1c recommended in all diabetic patients; HbA1c ≥ 7.8% associated with elevated wound complication risk in outpatient dermatologic procedures |
| Wong et al 2022 (meta-analysis) | General/Abdominal Surgery | Risk increases > 6%–7% | HbA1c > 7% associated with wound infection OR 1.21, indicating a 21% increase in odds of wound infection (95% Cl 1.08–1.36); risk begins to rise above 6%–7% baseline |
| Wound Healing Society Guidelines 2023 | Wound Care | < 7.0% for optimal healing | Optimizing glucose control improves wound healing outcomes in diabetic patients; chronic hyperglycemia is a central modifiable driver of impaired wound repair |
ADA = American Diabetes Association; CPOC = Centre for Perioperative Care (UK); ESC = European Society of Cardiology; SAMBA = Society for Ambulatory Anesthesia; ASPS = American Society of Plastic Surgeons; WHS = Wound Healing Society